9530008L14Rik activators encompass a diverse array of chemical compounds that indirectly boost the functional activity of 9530008L14Rik by modulating various intracellular signaling pathways. Forskolin and IBMX both act to increase intracellular cAMP levels, which in turn activate PKA; this activation can phosphorylate proteins that interact with 9530008L14Rik, leading to its functional enhancement. Similarly, PMA, through PKC activation, and sphingosine-1-phosphate through its receptor-mediated signaling, can initiate a cascade of phosphorylation events that bolster the activity of 9530008L14Rik within its specific signaling milieu. Genistein and Epigallocatechin gallate, as kinase inhibitors, reduce competitive signaling from tyrosine kinases and other kinases, respectively, which can result in the augmented functional activity of 9530008L14Rik by alleviating suppressive signaling influences.
Theactivity of 9530008L14Rik is further influenced by compounds that modulate phosphoinositide 3-kinases (PI3K) and mitogen-activated protein kinases (MAPK) signaling. LY294002, a PI3K inhibitor, may enhance 9530008L14Rik activity by diminishing competitive PI3K/Akt signaling, thus favoring 9530008L14Rik-related pathways. U0126 and SB203580, which inhibit MEK and p38 MAPK, respectively, could redirect signaling in a way that promotes 9530008L14Rik activity through their impact on these kinases and the associated signaling cascades. Furthermore, A23187 and Thapsigargin, by increasing intracellular calcium levels and thereby activating calcium-dependent signaling pathways, potentially enhance the activity of 9530008L14Rik. Lastly, Staurosporine may facilitate the selective activation of 9530008L14Rik pathways by inhibiting kinases that exert negative regulation on the signaling processes involving 9530008L14Rik. Collectively, these activators, through targeted effects on cellular signaling, foster the enhancement of 9530008L14Rik mediated functions without directly upregulating its expression or requiring direct activation of the protein.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective phosphodiesterase inhibitor that prevents cAMP degradation, potentially sustaining the activity of PKA. This sustained PKA activity could enhance the functional activity of 9530008L14Rik through downstream effects. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts on its receptors to stimulate intracellular signaling cascades, which may lead to the activation of pathways that enhance the activity of 9530008L14Rik. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a protein kinase C (PKC) activator. PKC activation can lead to phosphorylation events that may indirectly enhance the functional activity of 9530008L14Rik by influencing signaling cascades it participates in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can shift cell signaling towards pathways that 9530008L14Rik is involved in, potentially enhancing its activity by reducing competitive signaling. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an MEK inhibitor that can alter the MAPK pathway, potentially leading to an enhancement of the functional activity of 9530008L14Rik by impacting the related signaling processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that could redirect cellular signaling in a manner that enhances the functional activity of 9530008L14Rik by affecting pathways with which it interacts. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, potentially enhancing the activity of 9530008L14Rik through calcium-dependent signaling pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin elevates intracellular calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), which may indirectly enhance the functional activity of 9530008L14Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate is a kinase inhibitor that could influence signaling pathways in which 9530008L14Rik is involved, potentially enhancing its activity by reducing competitive signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that could lead to the enhanced functional activity of 9530008L14Rik by reducing competitive tyrosine kinase signaling that may otherwise suppress 9530008L14Rik pathways. | ||||||